Sha-Sha Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sha-Sha Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Chun-Hui Ni
1 shared publication- Fang Yuan
Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, PR China
1 shared publication - Gaojian Chen
State Key Laboratory of Bioinspired Interfacial Materials Science State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials College of Chemistry Chemical Engineering and Materials Science Soochow University Suzhou 215123 P. R. China
1 shared publication Hong-Quan Cai
1 shared publication- Hongliang Jiang
Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China
1 shared publication Jin Xu
School of Public Health, Nanjing Medical University, Nanjing 210029, China
1 shared publication
Latest Publications
- 1 October 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 122, 194-201
Novel chitosan-based pH-sensitive and disintegrable polyelectrolyte nanogels
- 1 October 2014
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 122, 194-201
Novel chitosan-based pH-sensitive and disintegrable polyelectrolyte nanogels
- 1 October 2010
- Vol. 28 (10) , 766-71
[SMAD4 gene polymorphisms and genetic susceptibility of coal work's pneumoconiosis].
To explore whether 6 tagging single nucleotide polymorphisms (SNPs) within SMAD4 gene were involved in the genetic susceptibility of coal worker's pneumoconiosis (CWP) by case-control study. this study consisted of 438 CWP patients and 448 controls. All study subjects were Han Chinese, underground coal miners and recruited from coal mines of Xuzhou Mining Business Group Co Ltd. The 5 ml venous blood sample was obtained from all studied subjects and extracted genome DNA from the isolated leucocytes. Six SNPs were selected from the HapMap and detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). the single SNP analyses showed that the genotype frequencies of SMAD4 (rs10502913) was significantly different from those in controls (P < 0.05). Multivariate logistic regression analyses revealed that SMAD4 (rs10502913) AA genotype was associated with increased risk of CWP (adjusted OR = 1.63, 95%CI = 1.00 - 2.69, P = 0.05) and this was evident among subgroups of those smoker (adjusted OR = 2.28, 95%CI = 1.09 ∼ 4.80, P < 0.05) and cases with stage I (adjusted OR = 2.42, 95%CI = 1.41 ∼ 4.14, P < 0.01). The SMAD4 (rs9304407) GG genotype was associated with an decreased risk of CWP (adjusted OR = 0.65, 95%CI = 0.43 ∼ 0.98, P < 0.05) and the further stratification analysis showed that the risk of CWP was decreased in nonsmoking groups. our results suggest that individuals with the SMAD4 (rs10502913) AA genotype was associated with an increased risk of CWP. However, carriers of SMAD4 (rs9304407) GG genotype have a protective effect on the developing CWP.
- 1 October 2010
- Vol. 28 (10) , 766-71
[SMAD4 gene polymorphisms and genetic susceptibility of coal work's pneumoconiosis].
To explore whether 6 tagging single nucleotide polymorphisms (SNPs) within SMAD4 gene were involved in the genetic susceptibility of coal worker's pneumoconiosis (CWP) by case-control study. this study consisted of 438 CWP patients and 448 controls. All study subjects were Han Chinese, underground coal miners and recruited from coal mines of Xuzhou Mining Business Group Co Ltd. The 5 ml venous blood sample was obtained from all studied subjects and extracted genome DNA from the isolated leucocytes. Six SNPs were selected from the HapMap and detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). the single SNP analyses showed that the genotype frequencies of SMAD4 (rs10502913) was significantly different from those in controls (P < 0.05). Multivariate logistic regression analyses revealed that SMAD4 (rs10502913) AA genotype was associated with increased risk of CWP (adjusted OR = 1.63, 95%CI = 1.00 - 2.69, P = 0.05) and this was evident among subgroups of those smoker (adjusted OR = 2.28, 95%CI = 1.09 ∼ 4.80, P < 0.05) and cases with stage I (adjusted OR = 2.42, 95%CI = 1.41 ∼ 4.14, P < 0.01). The SMAD4 (rs9304407) GG genotype was associated with an decreased risk of CWP (adjusted OR = 0.65, 95%CI = 0.43 ∼ 0.98, P < 0.05) and the further stratification analysis showed that the risk of CWP was decreased in nonsmoking groups. our results suggest that individuals with the SMAD4 (rs10502913) AA genotype was associated with an increased risk of CWP. However, carriers of SMAD4 (rs9304407) GG genotype have a protective effect on the developing CWP.